Impact of combined hormone replacement therapy on serum lipid metabolism: New aspects

Gynecological Endocrinology

Volumn 11, Issue 4, 1997, Pages 281-288

  Alexandersen, P ^a   Haarbo, J ^a   Christiansen, C ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Hormone replacement therapy; LDL particle size; Lipid metabolism

Indexed keywords

APOLIPOPROTEIN B; CYPROTERONE ACETATE; DESOGESTREL; ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS NORGESTREL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; LEVONORGESTREL;

ADULT; ARTICLE; CONTROLLED STUDY; DENMARK; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MENOPAUSE; NORMAL HUMAN; PARTICLE SIZE; POSTMENOPAUSE; PRIORITY JOURNAL; TIME;

EID: 0030873710     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152547     Document Type: Article

References (41)

1. Bush, T. L., Barrett-Connor, E., Cowan, L. D., Criqui, M. H., Wallace, R. B., Suchindran, C. M., Tyroler, H. A. and Rifkind, B. M. (1987). Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the lipid research clinics program follow-up study. Circulation, 75, 1102-9
2. Sullivan, J. M., Zwaag, R. V., Lemp, G. F., Hughes, J. P., Maddock, V., Kroetz, F. W., Ramanathan, K. B. and Mirvis, D.M. (1988). Postmenopausal estrogen use and coronary atherosclerosis. Ann. Int. Med., 108, 358-63
3. Witteman, J. C. M., Grobbee, D. E., Kok, F. J., Hofman, A. and Valkenburg, H. A. (1989). Increased risk of atherosclerosis in women after the menopause. Br. Med. J., 298, 642-4
4. Hough, J. L. and Zilversmit, D. B. (1986). Effect of 17β-estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis, 6, 57-63
5. Henriksson, P., Stambcrger, M., Eriksson, M., Rudling, M., Diczfalusy, U., Berglund, L. and Angelin, B. (1989). Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur. J. Clin. Invest., 19, 395-403
6. Adams, M. R., Kaplan, J. R., Manuck, S. B., Koritnik, D. R., Parks, J. S., Wolfe, M. S. and Clarkson, T. B. (1990). Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis, 10, 1051-7
7. Haarbo, J., Leth-Espensen, P., Stender, S. and Christiansen, C. (1991). Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J. Clin. Invest., 87, 1274-9
8. Haarbo, J., Hassager, C., Jensen, S. B., Riis, B. J. and Christiansen, C. (1991). Serum lipids, lipoproteins and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives. Am. J. Med., 90, 584-9
9. Stampfer, M. J. and Colditz, G. A. (1991). Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med., 20, 47-63
10. Bush, T. L. (1991). Extraskeletal effects of estrogen and the prevention of atherosclerosis. Osteoporosis Int., 2, 5-11
11. Consensus Report (1988). Progestogen use in postmenopausal women. Lancet, 2, 1243-4
12. Persson, I., Adami, H. O., Bergkvist, L., Lindgren, A., Pettersson, B., Hoover, R. and Schairer, C. (1989). Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. Br. Med. J., 298, 147-51
13. Hirvonen, E., Mälkönen, M. and Manninen, V. (1981). Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N. Engl. J. Med., 304, 560-3
14. Hirvonen, E., Lipasti, A., Mälkönen, M., Kärkäkinen, J., Nuntila, J., Timonen, H. and Manninen, V. (1987). Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in postmenopausal women. Maturitas, 9, 69-79
15. Fåhraeus, L., Larsson-Cohn, U. and Wallentin, L. (1983). L-norgestrel and progesterone have different influences on plasma lipoproteins. Eur. J. Clin. Invest., 13, 447-53
16. Ottoson, U. B., Johansson, B. G. and von Schoultz, B. (1985). Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone. Am. J. Obstet. Gynecol., 151, 746-50
17. Williams, P. T., Vranizan, K. M. and Krauss, R. M. (1992). Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women. J. Lipid Res., 33, 765-74
18. Feingold, K. R., Grundfeld, C., Pang, M., Doerrler, W. and Krauss, R. M. (1992). LDL subclass phenotypes and triglyceride metabolism in NIDDM. Arterioscler. Thomb., 12, 1496-1502
19. Tribble, D. L., Holl, L. G., Wood, P.D. and Krauss, R. M. (1992). Variations in oxidative susceptibility among six LDL subfractions of different density and particle size. Atherosclerosis, 93, 189-99
20. Austin, M. A., Breslow, J. L., Hennekens, C. H., Buring, J. E., Willett, W. C. and Krauss, R. M. (1988). Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc., 260, 1917-21
21. Krauss, R. M. (1993). Atherogenic lipoproteins in postmenopausal women. In Christiansen, C. and Riis, B. J. (eds.) Proceedings of the IVth International Symposium on Ostcoporosis, and Consensus Development Conference, pp. 275-7. (Hong Kong; Hand-elstrykkeriet Aalborg ApS)
22. Sniderman, A. D., Wolfson, C., Teng, B., Franklin, F. A., Bachorik, P. S. and Kwiterovich, P. O. (1982). Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann. Intern. Med., 97, 833-9
23. Brunzell, J. D., Albers, J.J., Chait, A., Grundy, S. M., Groszek, E. and McDonald, G. B. (1983). Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J. Lipid Res., 24, 147-55
24. Brunzell, J. D., Sniderman, A. D., Albers, J. J. and Kwiterovich, P. O. (1984). Apoproteins B and A-l and coronary artery disease in humans. Arteriosclerosis, 4, 79-83
25. Marslew, U., Overgaard, K., Riis, B. J. and Christiansen, C. (1992). Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Br. J. Obstet. Gynaecol., 79, 202-10
26. Friedewald, W. T., Levy, R. I. and Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin. Chem., 18, 499-502
27. Matthews, J. N. S., Altman, D. G., Campbell, M. J. and Royston, P. (1990). Analysis of serial measurements in clinical research. Br. Med. J., 300, 230-5
28. SAS Institute Inc. (1987). SAS/STAT Guide for Personal Computers, Version 6 (North Carolina: SAS Institute Inc.)
29. Camejo, G., Rosengren, B., Olson, U., Lopez, F., Olofson, S. O., Westerlund, C. and Bondjers, G. (1990). Molecular basis of the association of arterial wall proteoglycans with low density lipoproteins: its effect on the structure of the lipoprotein particle. Eur. Heart J., 11 (Suppl. E), 164-73
30. Austin, M. A., King, M. C., Vranizan, K. M., Newman, B. and Krauss, R. M. (1988). Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am. J. Hum. Genet., 43, 838-46
31. Campos, H., Wilson, P. W. F., Jiménez, D., McNamara, J. R., Ordovas, J. and Schaefer, E. J. (1990). Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study. Metabolism, 39, 1033-8
32. Moorjani, S., Dupont, A. and Labrie, F. (1991). Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with uterogestan in menopausal women. J. Clin. Endocrinol. Metab., 73, 373-9
33. Griffin, B., Farish, E. and Walsh, D. (1993). Response of low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause. Clin. Endocrinol., 39, 463-8
34. Scandinavian Simvastin Survival Study Group (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastin Survival Study. Lancet, 344, 1383-9
35. Riedel, M., Rafflenbeul, W. and Lichtlen, P. (1993). Ovarian sex steroids and atherosclerosis. Clin. Invest., 71, 406-12
36. Nègre-Salvayre, A., Pieraggi, M.-T., Mabile, L. and Salvayre, R. (1993). Protective effect of 17β-estradiol against the cytoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis, 99, 207-17
37. Wagner, J. D, Clarkson, T. B., Clair, R. W., Schwenke, D. C., Shively, C. A. and Adams, M. R. (1991). Estrogens and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J. Clin. Invest., 88, 1995-2002
38. Clarkson, T. B., Anthony, M. S. and Klein, K. P. (1994). Effects of estrogen treatment on arterial wall structure and function. Drugs, 47 (Suppl. 2), 42-51
39. Haarbo, J., Svendsen, O. L. and Christiansen, C. (1992). Progestogens to not affect aortic accumulation of cholesterol in ovariectomized cholesterolfed rabbits. Circ. Res., 70, 1198-202
40. Clarkson, T. B. (1994). Estrogens, progestins, and coronary heart disease in cynomolgus monkeys. Fertil. Steril., 62, 1478-518
41. Falkeborn, M., Persson, I., Adami, H.-O., Bergström, R., Eaker, E., Mohsen, H. L. R. and Naessén, T. (1992). The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br. J. Obstet. Gynaecol., 99, 821-8